Lunai Bioworks Inc. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
Lunai Bioworks Inc. (LNAI) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $16.68 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-05-15
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-03-31 was $16.68K.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-12-31 was $10.86K, a 99.89% decline year-over-year.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-09-30 was $10.94M.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was -$109.04M, a 9150.28% decline year-over-year.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was -$109.99M, a 78123.96% decline from fiscal 2024.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was $140.96K.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was -$554.00, a 102.83% decline from fiscal 2022.
- Lunai Bioworks Inc. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2022 was $19.60K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $16.68K 10-Q · filed 2026-05-15 | $27.54K derived: sum of 2 quarters · filed 2026-05-15 | $10.97M 10-Q · filed 2026-05-15 | -$98.07M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $10.86K 10-Q · filed 2026-02-17 | $10.95M 10-Q · filed 2026-02-17 | -$98.09M derived: sum of 3 quarters · filed 2026-02-17 | -$102.71M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-09-30 | $10.94M 10-Q · filed 2025-11-14 | -$98.10M derived: sum of 2 quarters · filed 2025-11-14 | -$102.72M derived: sum of 3 quarters · filed 2026-05-15 | -$92.57M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | -$109.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$113.66M derived: sum of 2 quarters · filed 2026-05-15 | -$103.52M derived: sum of 3 quarters · filed 2026-05-15 | -$109.99M 10-K · filed 2025-09-29 | |||
| 2025-03-31 | -$4.62M 10-Q · filed 2026-05-15 | $5.52M derived: sum of 2 quarters · filed 2026-05-15 | -$946.46K 10-Q · filed 2026-05-15 | $258.36K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $10.14M 10-Q · filed 2026-02-17 | $3.68M 10-Q · filed 2026-02-17 | $4.88M derived: sum of 3 quarters · filed 2026-02-17 | $3.82M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-09-30 | -$6.47M 10-Q · filed 2025-11-14 | -$5.26M derived: sum of 2 quarters · filed 2025-11-14 | -$6.32M derived: sum of 3 quarters · filed 2025-11-14 | -$6.36M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $143.62K derived: sum of 2 quarters · filed 2025-09-29 | $106.36K derived: sum of 3 quarters · filed 2025-09-29 | $140.96K 10-K · filed 2025-09-29 | |||
| 2024-03-31 | -$1.06M 10-Q · filed 2025-05-15 | -$1.10M derived: sum of 2 quarters · filed 2025-05-15 | -$1.06M 10-Q · filed 2025-05-15 | -$1.07M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$37.25K 10-Q · filed 2025-02-19 | -$2.65K 10-Q · filed 2025-02-19 | -$5.15K derived: sum of 3 quarters · filed 2025-02-19 | -$3.04K derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-09-30 | $34.60K 10-Q/A · filed 2025-02-19 | $32.10K derived: sum of 2 quarters · filed 2025-02-19 | $34.21K derived: sum of 3 quarters · filed 2025-02-19 | $26.29K derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | -$2.50K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | -$393.00 derived: sum of 2 quarters · filed 2025-02-19 | -$8.31K derived: sum of 3 quarters · filed 2025-02-19 | -$554.00 10-K/A · filed 2025-02-19 | |||
| 2023-03-31 | $2.11K 10-Q/A · filed 2025-02-19 | -$5.80K derived: sum of 2 quarters · filed 2025-02-19 | $1.95K 10-Q/A · filed 2025-02-19 | $10.89K derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | -$7.92K 10-Q · filed 2024-02-14 | -$161.00 10-Q · filed 2024-02-14 | $8.78K derived: sum of 3 quarters · filed 2024-02-14 | $11.46K derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-09-30 | $7.75K 10-Q · filed 2023-11-14 | $16.70K derived: sum of 2 quarters · filed 2023-11-14 | $19.37K derived: sum of 3 quarters · filed 2023-11-14 | $23.36K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $8.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $11.62K derived: sum of 2 quarters · filed 2023-10-02 | $15.61K derived: sum of 3 quarters · filed 2023-10-02 | $19.60K 10-K · filed 2023-10-02 | |||
| 2022-03-31 | $2.68K 10-Q · filed 2023-05-12 | $6.67K derived: sum of 2 quarters · filed 2023-05-12 | $10.66K 10-Q · filed 2023-05-12 | $8.57K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $3.99K 10-Q · filed 2023-03-09 | $7.98K 10-Q · filed 2023-03-09 | $5.89K derived: sum of 3 quarters · filed 2023-03-09 | $15.72K derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2021-09-30 | $3.99K 10-Q · filed 2023-03-07 | $1.91K derived: sum of 2 quarters · filed 2023-03-07 | $11.73K derived: sum of 3 quarters · filed 2023-03-07 | $1.80K derived: sum of 4 quarters · filed 2023-03-07 | |||
| 2021-06-30 | -$2.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.74K derived: sum of 2 quarters · filed 2023-02-27 | -$2.19K derived: sum of 3 quarters · filed 2023-02-27 | -$30.58K 10-K · filed 2023-02-27 | |||
| 2021-03-31 | $9.83K 10-Q · filed 2022-05-13 | -$105.00 derived: sum of 2 quarters · filed 2022-05-13 | -$28.49K 10-Q · filed 2022-05-13 | -$42.82K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$9.93K 10-Q · filed 2022-02-14 | -$38.32K 10-Q · filed 2022-02-14 | -$52.65K derived: sum of 3 quarters · filed 2022-02-14 | -$42.45K derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | -$28.39K 10-Q · filed 2021-11-15 | -$42.72K derived: sum of 2 quarters · filed 2021-11-15 | -$32.52K derived: sum of 3 quarters · filed 2021-11-15 | -$163.81K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$14.33K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | -$4.13K derived: sum of 2 quarters · filed 2021-09-24 | -$135.42K derived: sum of 3 quarters · filed 2021-09-24 | $143.23K 10-K · filed 2021-09-24 | |||
| 2020-03-31 | $10.20K 10-Q · filed 2021-05-17 | -$121.09K derived: sum of 2 quarters · filed 2021-05-17 | $157.56K 10-Q · filed 2021-05-17 | $254.57K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$131.29K 10-Q · filed 2021-02-16 | $147.37K 10-Q · filed 2021-02-16 | $244.37K derived: sum of 3 quarters · filed 2021-02-16 | $384.08K derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | $278.66K 10-Q · filed 2020-11-12 | $375.66K derived: sum of 2 quarters · filed 2020-11-12 | $515.37K derived: sum of 3 quarters · filed 2020-11-12 | $291.00K derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $236.72K derived: sum of 2 quarters · filed 2020-09-23 | $12.35K derived: sum of 3 quarters · filed 2020-09-23 | $103.86K 10-K · filed 2020-09-23 | |||
| 2019-03-31 | $139.71K 10-Q · filed 2020-05-11 | -$139.71K 10-Q · filed 2019-05-16 | -$84.66K derived: sum of 2 quarters · filed 2020-05-11 | $6.86K 10-Q · filed 2020-05-11 | -$466.53K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$224.37K 10-Q · filed 2020-05-11 | -$226.39K 10-Q · filed 2019-02-13 | -$132.85K 10-Q · filed 2020-02-10 | -$130.83K 10-Q · filed 2019-02-13 | -$606.24K derived: sum of 3 quarters · filed 2020-05-11 | -$370.28K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-09-30 | $91.52K 10-Q · filed 2020-05-11 | -$381.87K derived: sum of 2 quarters · filed 2020-05-11 | -$145.91K derived: sum of 3 quarters · filed 2020-05-11 | -$15.92K derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-06-30 | -$473.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | -$237.43K derived: sum of 2 quarters · filed 2019-09-30 | -$107.44K derived: sum of 3 quarters · filed 2019-09-30 | $147.15K 10-K · filed 2019-09-30 | $147.25K 10-K · filed 2018-10-01 | ||
| 2018-03-31 | $235.96K 10-Q · filed 2019-05-16 | $365.95K derived: sum of 2 quarters · filed 2019-05-16 | $620.54K 10-Q · filed 2019-05-16 | $1.10M derived: sum of 4 quarters · filed 2019-05-16 | |||
| 2017-12-31 | $129.99K 10-Q · filed 2019-02-13 | $384.58K 10-Q · filed 2019-02-13 | $867.62K derived: sum of 3 quarters · filed 2019-02-13 | $975.19K derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-09-30 | $255.18K 10-Q · filed 2018-11-14 | $737.63K derived: sum of 2 quarters · filed 2018-11-14 | $845.20K derived: sum of 3 quarters · filed 2018-11-14 | $440.99K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $482.44K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-01 | $590.02K derived: sum of 2 quarters · filed 2018-10-01 | $185.81K derived: sum of 3 quarters · filed 2018-10-01 | $211.46K 10-K · filed 2018-10-01 | |||
| 2017-03-31 | $107.58K 10-Q · filed 2018-05-15 | -$296.63K derived: sum of 2 quarters · filed 2018-05-15 | -$270.98K 10-Q · filed 2017-05-15 | -$452.64K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$404.21K 10-Q · filed 2018-02-09 | -$378.62K 10-Q · filed 2018-02-09 | -$560.21K derived: sum of 3 quarters · filed 2018-02-09 | -$262.61K derived: sum of 4 quarters · filed 2018-02-09 | |||
| 2016-09-30 | $25.59K 10-Q · filed 2017-11-20 | -$156.00K derived: sum of 2 quarters · filed 2017-11-20 | $141.60K derived: sum of 3 quarters · filed 2017-11-20 | -$4.63K derived: sum of 4 quarters · filed 2017-11-20 | |||
| 2016-06-30 | -$181.59K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-20 | $116.01K derived: sum of 2 quarters · filed 2017-11-20 | -$30.22K derived: sum of 3 quarters · filed 2017-11-20 | -$20.70K 10-K · filed 2017-11-20 | |||
| 2016-03-31 | $297.60K 10-Q · filed 2017-05-15 | $151.37K derived: sum of 2 quarters · filed 2017-05-15 | $160.89K 10-Q · filed 2017-05-15 | $335.42K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$146.23K 10-Q · filed 2017-02-14 | -$136.42K 10-Q · filed 2017-02-14 | $37.82K derived: sum of 3 quarters · filed 2017-02-14 | -$404.76K derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-09-30 | $9.82K 10-Q · filed 2016-11-14 | $184.05K derived: sum of 2 quarters · filed 2016-11-14 | -$258.53K derived: sum of 3 quarters · filed 2016-11-14 | -$334.26K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $174.23K derived: 10-K 6 month − 10-Q 3 month · filed 2016-09-28 | -$268.34K 10-K · filed 2016-09-28 | -$344.08K derived: sum of 3 quarters · filed 2016-09-28 | -$559.70K derived: sum of 4 quarters · filed 2016-09-28 | |||
| 2015-03-31 | -$442.57K 10-Q · filed 2016-05-13 | -$518.31K derived: sum of 2 quarters · filed 2016-05-13 | -$733.93K 10-Q · filed 2016-05-13 | -$745.66K derived: sum of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | -$75.74K 10-Q · filed 2016-02-12 | -$291.36K 10-Q · filed 2016-02-12 | -$303.08K derived: sum of 3 quarters · filed 2016-02-12 | -$306.44K 10-K · filed 2016-09-28 | $306.44K 10-K · filed 2015-03-31 | ||
| 2014-09-30 | -$215.62K 10-Q · filed 2014-11-13 | -$227.35K derived: sum of 2 quarters · filed 2015-11-13 | -$230.70K 10-Q · filed 2014-11-13 | $128.84K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | -$11.73K 10-Q · filed 2014-08-14 | -$15.08K 10-KT · filed 2015-09-28 | $344.46K derived: sum of 3 quarters · filed 2015-09-28 | $270.44K derived: sum of 4 quarters · filed 2015-09-28 | |||
| 2014-03-31 | $3.35K 10-Q · filed 2015-05-13 | $356.19K derived: sum of 2 quarters · filed 2015-09-28 | $282.17K derived: sum of 3 quarters · filed 2015-09-28 | $83.77K derived: sum of 4 quarters · filed 2015-09-28 | |||
| 2013-12-31 | $352.83K derived: 10-KT 12 month − 10-Q 9 month · filed 2015-09-28 | $278.81K derived: sum of 2 quarters · filed 2015-09-28 | $80.42K derived: sum of 3 quarters · filed 2015-09-28 | $219.47K 10-KT · filed 2015-09-28 | |||
| 2013-09-30 | -$74.02K 10-Q · filed 2014-11-13 | -$272.42K derived: sum of 2 quarters · filed 2014-11-13 | -$133.37K 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | -$198.40K 10-Q · filed 2014-08-14 | $59.34K 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | $139.05K 10-Q · filed 2014-05-14 | ||||||
| 2012-12-31 | -$85.70K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |